Bin Huang

2PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 13, 2025
MTHFD2 Enhances cMYC O-GlcNAcylation to Promote Sunitinib Resistance in Renal Cell Carcinoma.

Jinwen Liu, Gaowei Huang, Hao Lin

|Mar 13, 2024
Bladder-sparing treatment using tislelizumab combined with gemcitabine/cisplatin in selected patients with muscle-invasive bladder cancer: a real-world study.

Cheng Luo, Shuhang Luo, Wumier Wusimanjiang

Pageof 1